Table 1.
Demographics, injury severity, and outcomes by coagulopathy
| Median (IQR) | ATC N=439 (23%) |
NON-ATC N=1438 (77%) |
p |
|---|---|---|---|
| Age | 38 (22–57) | 43 (28–55) | <0.01* |
| Gender (% male) | 66.3 | 66.6 | 0.95 |
| ISS | 38 (27–50) | 29 (22–41) | <0.01* |
| APACHE II | 32 (28–36) | 28 (24–33) | <0.01* |
| Initial base deficit | 9.7 (6.8–13.1) | 7.6 (5.3–10.9) | <0.01* |
| INR | 1.9 (1.7–2.3) | 1.2 (1.1–1.3) | <0.01* |
| 24hr blood requirement | 10.5 (5.7–18.7) | 5 (2.7–9.33) | <0.01* |
| 24hr FFP requirement | 7.2 (3.5–11.8) | 1.6 (0–4.8) | <0.01* |
| 24hr platelet requirement | 0.9 (0–1.8) | 0 (0–0.9) | <0.01* |
| 24hr crystalloid requirement | 14.9 (10.4–20.8) | 12.2 (8.9–16.6) | <0.01* |
| Massive transfusion (%) | 52.2 | 23.4 | <0.01* |
| Early surgery (%) | 53.5 | 40.8 | <0.01* |
| Coumadin (%) | 6.2 | 0.6 | <0.01* |
| ICU days | 9 (4–17) | 12 (5–19) | <0.01* |
| In-hospital mortality (%) | 26.2 | 11.4 | <0.01* |
| MOF (%) | 38.7 | 27.7 | <0.01* |
*
p < 0.05